NEXGEL completes Celularity acquisition with $5.5 million financing
Tweet Send to a Friend
NEXGEL Inc. (NASDAQ: NXGL) completed its acquisition of regenerative biomaterials products from Celularity Inc. (NASDAQ: CELU), financed by a $5.5 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
